Current and former members of the board of directors include Liam Dolan, Stephen G. Davies, Lionel Tarassenko, John Bell, Mike Brady and David Cooksey.

[11] Oxford University Innovation licenses technologies to companies who invest in developing and selling the products in a timely and ethical manner.

Members receive an advance notification of all patent applications marketed by Oxford University Innovation, invitations to networking opportunities at formal OIS dinners, customised research presentations and bespoke seminars for technology roadmapping and strategic planning.

The open fund allows anyone to donate money which goes towards helping create prototypes or proof-of-concept models from ideas and technologies developed at Oxford to improve the transfer into a commercial setting.

These questionnaires, developed within the university, are used for academic and commercial clinical studies into a variety of illnesses,[14] including Parkinson's disease[15] and endometriosis.

The negotiation of sales agreements for biological and physical science materials such as cell lines and antibodies are also handled by Isis Innovation.